Author:
Dötsch Andreas,Klawonn Frank,Jarek Michael,Scharfe Maren,Blöcker Helmut,Häussler Susanne
Abstract
Abstract
Background
The constant increase in development and spread of bacterial resistance to antibiotics poses a serious threat to human health. New sequencing technologies are now on the horizon that will yield massive increases in our capacity for DNA sequencing and will revolutionize the drug discovery process. Since essential genes are promising novel antibiotic targets, the prediction of gene essentiality based on genomic information has become a major focus.
Results
In this study we demonstrate that pooled sequencing is applicable for the analysis of sequence variations of strain collections with more than 10 individual isolates. Pooled sequencing of 36 clinical Pseudomonas aeruginosa isolates revealed that essential and highly expressed proteins evolve at lower rates, whereas extracellular proteins evolve at higher rates. We furthermore refined the list of experimentally essential P. aeruginosa genes, and identified 980 genes that show no sequence variation at all. Among the conserved nonessential genes we found several that are involved in regulation, motility and virulence, indicating that they represent factors of evolutionary importance for the lifestyle of a successful environmental bacterium and opportunistic pathogen.
Conclusion
The detailed analysis of a comprehensive set of P. aeruginosa genomes in this study clearly disclosed detailed information of the genomic makeup and revealed a large set of highly conserved genes that play an important role for the lifestyle of this microorganism. Sequencing strain collections enables for a detailed and extensive identification of sequence variations as potential bacterial adaptation processes, e.g., during the development of antibiotic resistance in the clinical setting and thus may be the basis to uncover putative targets for novel treatment strategies.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Obrecht D, Robinson JA, Bernardini F, Bisang C, DeMarco SJ, Moehle K, Gombert FO: Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics. Curr Med Chem. 2009, 16: 42-65. 10.2174/092986709787002844.
2. Rasmussen TB, Givskov M: Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol. 2006, 296: 149-161. 10.1016/j.ijmm.2006.02.005.
3. Pathania R, Brown ED: Small and lethal: searching for new antibacterial compounds with novel modes of action. Biochem Cell Biol. 2008, 86: 111-115. 10.1139/O08-011.
4. Payne DJ, Gwynn MN, Holmes DJ, Rosenberg M: Genomic approaches to antibacterial discovery. Methods Mol Biol. 2004, 266: 231-259.
5. Dutta A, Singh SK, Ghosh P, Mukherjee R, Mitter S, Bandyopadhyay D: In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol. 2006, 6: 43-47.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献